VN November 2026

Vetnuus | November 2026 37 4. CONCLUSION The present investigation demonstrated that high-fat diet feeding significantly aggravated metabolic derangements and accelerated the progression of cardiac and renal dysfunction in streptozotocininduced diabetic rats. Persistent hyperglycaemia, progressive dyslipidaemia, and marked body weight reduction reflected severe metabolic imbalance. Significant elevations in blood urea nitrogen, serum creatinine, and CK-MB substantiated the development of diabetic nephropathy and cardiomyopathy. The progressive deterioration observed from day 14 to day 28 indicated timedependent exacerbation of target organ damage under sustained hyperglycaemic conditions. v REFERENCES: Abdel-Rahim, E.A., Rashed, M.M., El-Hawary, Z.M., Abdelkader, M.M., Kassem, S.S., Mohamed, R.S., 2016. Anti-diabetic effect of Cichorium intybus leaves and Plantago ovata seeds in high-fat diets in streptozotocin-induced diabetic rats. Journal of Food and Nutrition Research 4(5), 276–281. DOI: 10.12691/jfnr-4-5-2. Adiels, M., Olofsson, S.O., Taskinen, M.R., Boren, J., 2008. Overproduction of very low–density lipoproteins is the hallmark of dyslipidemia in the metabolic syndrome. Arteriosclerosis, Thrombosis, andVascular Biology 28(7), 1225–1236. DOI: https://doi. org/10.1161/atvbaha.107.160192. AAkbarzadeh, A., Norouzian, D., Mehrabi, M.R., Jamshidi, S.H., Farhangi, A., Verdi, A.A., Rad, B.L., 2007. Induction of diabetes by streptozotocin in rats. Indian Journal of Clinical Biochemistry 22(2), 60–64. DOI: https://doi. org/10.1007/bf02913315. Al-Qabbaa, S.M., Qaboli, S.I., Alshammari, T.K., Alamin, M.A., Alrajeh, H.M., Almuthnabi, L.A., Alrasheed, N.M., 2023. Sitagliptin mitigates diabetic nephropathy in a rat model of streptozotocin-induced type 2 diabetes: possible role of PTP1B/JAK-STAT pathway. International Journal of Molecular Sciences 24(7), 6532. DOI: 10.3390/ijms24076532. Ansley, D.M., Wang, B., 2013. Oxidative stress and myocardial injury in the diabetic heart. The Journal of Pathology 229(2), 232–241. DOI: 10.1002/ path. 4113. Babu, P.V.A., Liu, D., Gilbert, E.R., 2013. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. The Journal of Nutritional Biochemistry 24, 1777–1789. DOI: 10.1016/j. jnutbio.2013.06.003. Brito, A.K.D.S., Mendes, A.V.D.S., Timah Acha, B., Santos Oliveira, A.S.D.S., Lopes Macedo, J., Suzuki Cruzio, A., Arcanjo, D.D.R., 2025. Experimental models of type 2 diabetes mellitus induced by combining hyperlipidemic diet (HFD) and streptozotocin administration in rats: an integrative review. Biomedicines 13(5), 1158. DOI: 10.3390/ biomedicines13051158. Cai, L., Kang, Y.J., 2003. Cell death and diabetic cardiomyopathy. Cardiovascular Toxicology 3(3), 219–228. DOI: https://doi.org/10.1385/ct:3:3:219. Chawla, A., Chawla, R., Jaggi, S., 2016. Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian Journal of Endocrinology and Metabolism 20(4), 546–551. DOI: 10.4103/22308210.183480. Forbes, J.M., Cooper, M.E., 2013. Mechanisms of diabetic complications. Physiological Reviews 93, 137–188. DOI: https://doi.org/10.1152/ physrev.00045.2011. Goldberg, I.J., 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Journal of Lipid Research, 37(4), 693–707. PMID: 8732771. DOI: https://doi.org/10.1016/S00222275(20)37569-6. Guo, S., 2014. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. The Journal of Endocrinology 220(2), T1–T23. DOI: 10.1530/JOE-13-0327. Hao, H.H., Shao, Z.M., Tang, D.Q., Lu, Q., Chen, X., Yin, X.X., Wu, J., Chen, H., 2012. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sciences 91(19-20), 959–967. DOI: 10.1016/j.lfs.2012.09.003. Huang, K.C., Chuang, P.Y., Yang, T.Y., Tsai, Y.H., Li, Y.Y., Chang, S.F., 2024. Diabetic rats induced using a high-fat diet and low-dose streptozotocin treatment exhibit gut microbiota dysbiosis and osteoporotic bone pathologies. Nutrients 16(8), 1220. DOI: 10.3390/ nu16081220. International Diabetes Federation, 2021. https://www.ncbi. nlm.nih.gov/ books/NBK581934/. DOI: http://dx.doi. org/10.5772. King, A.J., 2012. The use of animal models in diabetes research. British Journal of Pharmacology 166(3), 877–894.DOI: https://doi.org/10.1111/ j.14765381.2012.01911.x. Lewis, G.F., Carpentier, A., Adeli, K., Giacca, A., 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews 23(2), 201–229. DOI: doi.org/10.1210/edrv.23.2.0461. Lozano, I., Van der Werf, R., Bietiger, W., Seyfritz, E., Peronet, C., Pinget, M., Dal, S., 2016. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutrition and Metabolism 13(1), 15. DOI: 10.1186/s 12986-016-0074-1. Nicolle, E., Souard, F., Faure, P., Boumendjel, A., 2011. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure activity relationship. Current Medicinal Chemistry 18, 2661–2672. DOI: 10.2174/092986711795933777. Olefsky, J.M., 2001. Prospects for research in diabetes mellitus. JAMA 285(5), 628–632. DOI: 10.1001/ jama.285.5.628. Parveen, A., Sultana, R., Lee, S.M., Kim, T.H., Kim, S.Y., 2021. Phytochemicals against anti-diabetic complications: Targeting the advanced glycation end product signaling pathway. Archives of Pharmacal Research 44(4), 378– 401. https://doi.org/10.1007/ s12272-021-01323-9. Prabhakar, P.K., 2016. Pathophysiology of secondary complications of diabetes mellitus. Pathophysiology 9(1),32–36. Available from: https:// www.researchgate.net/ publication/290455800_Pathophysiology_of_ secondary_complications_of_diabetes_mellitus. Rather, I.A., Khan, N., Kushwah, A.S., Surampalli, G., Kumar, M., 2023. Nephroprotective effects of honokiol in a high-fat dietstreptozotocin rat model of diabetic nephropathy. Life Sciences 320, 121543. DOI: 10.1016/j.lfs.2023.121543. Samuel, V.T., Shulman, G.I., 2012. Mechanisms for insulin resistance: common threads and missing links. Cell 148(5), 852–871. DOI: https://doi. org/10.1016/j.cell.2012.02.017. Skyler, J.S., 2004. Diabetes mellitus: Pathogenesis and treatment strategies. Journal of Medicinal Chemistry 47(17), 4113–4117. DOI: https://doi. org/10.1021/ jm0306273. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L. Ramarao, P.J.P.R., 2005. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 52(4), 313–320. https://doi.org/10.1016/j. phrs.2005.05.004. Tam, A.A., Altay, F.P., Demir, P., Ozdemir, D., Topaloglu, O., Ersoy, R., Cakır, B., 2024. The association between diabetic nephropathy and triglyceride/ glucose index and Triglyceride/high-density lipoprotein cholesterol ratio in patients with type 2 diabetes mellitus. Journal of Clinical Medicine 13(22), 6954. DOI: https://doi. org/10.3390/jcm13226954. Tesch, G.H., Allen, T.J., 2007. Rodent models of streptozotocin-induced diabetic nephropathy (Methods in Renal Research). Nephrology 12(3), 261–266. DOI: https://doi.org/10.1111/j.1440-1797.2007.00796 Wickramasinghe, A.S.D., Attanayake, A.P., Kalansuriya, P., 2022. Biochemical characterization of high-fat diet-fed and low-dose streptozotocin-induced diabetic Wistar rat model. Journal of Pharmacological and Toxicological Methods 113, 107144. DOI: https:// doi.org/10.1016/j.vascn.2021.107144. Wu, T., Ding, L., Andoh, V., Zhang, J., Chen, L., 2023. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life 13(2), 539. DOI: doi.org/10.3390/life13020539. Youssef, M.E., El-Azab, M.F., Abdel-Dayem, M.A., Yahya, G., Alanazi, I.S., Saber, S., 2022. Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats. Environmental Science and Pollution Research 29(17), 25723–25732. Available from: https://ncmrjournal.com. tr/wp-content/ uploads/2025/08/ncmr-vol-2.2.2.pdf. Zhang, Y., Wang, P., Xu, Y., Meng, X., Zhang, Y., 2016. Metabolomic analysis of biochemical changes in the plasma of high-fat diet- and streptozotocininduced diabetic rats after treatment with isoflavone extract of Radix Puerariae. Evidence-Based Complementary and Alternative Medicine, 2016, 4701890. DOI: https:// doi.org/10.1155/2016/4701890. Ziyadeh, F.N., 1993. The extracellular matrix in diabetic nephropathy. American Journal of Kidney Diseases 22(5), 736–744. DOI: https://doi. org/10.1016/s0272-6386(12)80440-9. Article

RkJQdWJsaXNoZXIy OTc5MDU=